Bastiano Sanna
Analyst
Chief of Vertex Cell and Genetic Therapies
Equibles does not estimate personal net worth.
About Bastiano Sanna
Bastiano Sanna is recorded as Analyst at Chief of Vertex Cell and Genetic Therapies. Earlier roles on record: Board Member at Adicet Bio, Inc. (ACET) until November 7, 2023 and Board Member at Adicet Bio, Inc. (ACET) until March 2, 2021. Vertex Pharmaceuticals Inc / Ma is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc / Ma includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
Affiliation history
-
Chief of Vertex Cell and Genetic Therapies
Analyst
Source not stated
Current -
Vertex Pharmaceuticals Inc / Ma (VRTX)
Source not stated
Current -
2020-01-01–2023-11-07
-
2020-01-01–2021-03-02
Company network
Leadership on record at Vertex Pharmaceuticals Inc / Ma
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Jeffrey Leiden Chairman, Board Member
- Charles Wagner CFO
- Jonathan Poole CFO
- Charles F. Wagner, Jr. COO
- Alan Garber Board Member
- Bruce Sachs Board Member
- Diana McKenzie Board Member
Recent activity
No call appearances or filed executive changes recorded yet.